About meningoco ccal group
Meningococcal conjugate vaccine
Used for
- Prevents invasive meningococcal disease caused by groups A, C, W, and Y
Usual adult dose
Ages 18–55: one 0.5 mL injection into muscle. Additional doses or boosters depend on risk and vaccination history.
Usual dose in children
Ages 9–23 months: two 0.5 mL intramuscular doses, three months apart. Ages 2–17: usually one dose; boosters depend on risk.
Common side effects
- Injection-site pain, redness, or swelling
- Headache
- Tiredness
- Fever
Important warnings
- Avoid after severe allergy to a previous dose or ingredients
- Fainting can occur after vaccination
- History of Guillain-Barré syndrome requires careful risk assessment
- Does not protect against meningococcal group B
Pregnancy
Pregnancy data are limited. Vaccination may be given when protection is needed.
Breastfeeding
Breastfeeding is not a contraindication to this non-live vaccine.
Interactions
- Immunosuppressive medicines may reduce the immune response
- Some pneumococcal vaccines require specific timing in high-risk children
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.